{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-021203","form_type":"8-K","ticker":"ATEC","cik":"0001350653","company_name":"Alphatec Holdings, Inc.","filed_at":"2024-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.924886+00:00","generated_at":"2026-06-05T11:09:34.148078+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Alphatec reports FY2023 revenue $482M (+37% YoY); guides FY2024 revenue ~$595M","bullets":["Full-year 2023 revenue $482M, up 37% YoY; Q4 revenue $138M, surgical revenue growth 34%.","GAAP net loss of $187M for FY2023; Q4 net loss $49M.","FY2024 revenue guidance ~$595M, implying ~23% YoY growth; adjusted EBITDA margin expansion ~560 bps.","Adjusted EBITDA (updated definition) FY2023: ($9M) vs prior $4M; Q4: $2M.","Trained over 500 surgeons in 2023; surgeon users up 27% YoY."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-021203","json":"https://secwatch.observer/filing/0000950170-24-021203.json","markdown":"https://secwatch.observer/filing/0000950170-24-021203.md","text":"https://secwatch.observer/filing/0000950170-24-021203.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1350653/000095017024021203/0000950170-24-021203-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1350653/000095017024021203/atec-20240227.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T11:09:34.148078+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e880fba9c3c10777bd77051670e78bb0668ef659","claim":"Alphatec Holdings, Inc. reported year ended December 31, 2023 results: revenue $482 million.","evidence_excerpt":"(EX-99.1) --- EX-99.1 Exhibit 99.1 ATEC Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Highlights Full year 2023 total revenue grew 37% to $482 million Full year 2023 adjusted EBITDA margin improved ~890 basis points Full year 2024 total revenue expected to approximate $595 million, enabling adjusted EBITDA margin expansion of","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1350653/000095017024021203/0000950170-24-021203-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"year ended December 31, 2023"},{"label":"Revenue","value":"$482 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}